NasdaqCM - Delayed Quote USD
Apollomics, Inc. (APLMW)
0.0085
-0.0065
(-43.33%)
At close: May 9 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
13,098
55,387
76,475
123,437
Total Liabilities Net Minority Interest
8,234
14,153
524,595
336,299
Total Equity Gross Minority Interest
4,864
41,234
-448,120
-212,862
Total Capitalization
4,864
41,234
-448,120
-212,862
Common Stock Equity
4,864
41,234
-448,120
-212,862
Capital Lease Obligations
966
425
991
1,036
Net Tangible Assets
3,127
26,477
-462,898
-227,660
Working Capital
2,868
26,369
43,433
85,812
Invested Capital
4,864
45,470
-448,120
-212,862
Tangible Book Value
3,127
26,477
-462,898
-227,660
Total Debt
966
4,661
991
1,036
Share Issued
1,099.7030
894.9570
80,447.2600
80,447.2600
Ordinary Shares Number
1,099.7030
894.9570
80,447.2600
80,447.2600
12/31/2021 - 3/30/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SRZNW Surrozen, Inc.
0.0230
0.00%
PTIXW Protagenic Therapeutics, Inc.
0.0073
-1.35%
TCBWF TC Biopharm (Holdings) Plc
0.0089
0.00%
KLTOW Klotho Neurosciences, Inc.
0.0159
+1.92%
COEPW Coeptis Therapeutics Holdings, Inc.
0.0296
+18.88%
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0070
+100.00%
KMSTF Kadimastem Ltd
5.06
0.00%
DRMAW Dermata Therapeutics, Inc.
0.0249
0.00%
OSRHW OSR Holdings, Inc.
0.0313
-28.86%
NLSPW NLS Pharmaceutics AG
0.0097
+136.59%